Published in Ann Pharmacother on May 22, 2007
Study of High Dose Intravenous (IV) Ascorbic Acid in Measurable Solid Tumor Disease | NCT01125449
Effect of high-dose intravenous vitamin C on inflammation in cancer patients. J Transl Med (2012) 1.09
Redox-active antioxidant modulation of lipid signaling in vascular endothelial cells: vitamin C induces activation of phospholipase D through phospholipase A2, lipoxygenase, and cyclooxygenase. Mol Cell Biochem (2008) 0.84
Intravenous ascorbic acid to prevent and treat cancer-associated sepsis? J Transl Med (2011) 0.81
Schedule Dependence in Cancer Therapy: Intravenous Vitamin C and the Systemic Saturation Hypothesis. J Orthomol Med (2012) 0.75
Vitamin C pharmacokinetics: implications for oral and intravenous use. Ann Intern Med (2004) 4.30
Endometrial regenerative cells: a novel stem cell population. J Transl Med (2007) 2.19
Changes in USDA food composition data for 43 garden crops, 1950 to 1999. J Am Coll Nutr (2004) 1.76
Immunotherapy for melanoma: current status and perspectives. J Immunother (2010) 1.72
Cutaneous sarcoidosis and malignancy: An association between sarcoidosis with skin manifestations and systemic neoplasia. Dermatol Online J (2011) 1.49
Intravenously administered vitamin C as cancer therapy: three cases. CMAJ (2006) 1.43
Exosomes as a tumor immune escape mechanism: possible therapeutic implications. J Transl Med (2008) 1.28
Allogeneic endometrial regenerative cells: an "Off the shelf solution" for critical limb ischemia? J Transl Med (2008) 1.27
Mesenchymal stem cells as anti-inflammatories: implications for treatment of Duchenne muscular dystrophy. Cell Immunol (2010) 1.19
Orthomolecular oncology review: ascorbic acid and cancer 25 years later. Integr Cancer Ther (2005) 1.15
Physiogenomic analysis of the Puerto Rican population. Pharmacogenomics (2009) 1.11
Feasibility investigation of allogeneic endometrial regenerative cells. J Transl Med (2009) 1.10
Safety evaluation of allogeneic umbilical cord blood mononuclear cell therapy for degenerative conditions. J Transl Med (2010) 1.09
Feasibility of combination allogeneic stem cell therapy for spinal cord injury: a case report. Int Arch Med (2010) 1.09
A pilot clinical study of continuous intravenous ascorbate in terminal cancer patients. P R Health Sci J (2005) 1.08
Tumor vaccines in 2010: need for integration. Cell Immunol (2010) 1.02
Intravenous ascorbic acid: protocol for its application and use. P R Health Sci J (2003) 0.96
Intravenous vitamin C as a chemotherapy agent: a report on clinical cases. P R Health Sci J (2004) 0.95
Pharmacokinetics of vitamin C: insights into the oral and intravenous administration of ascorbate. P R Health Sci J (2008) 0.95
Effect of weight reduction on cardiovascular risk factors and CD34-positive cells in circulation. Int J Med Sci (2011) 0.95
L-Ascorbic acid induces apoptosis in acute myeloid leukemia cells via hydrogen peroxide-mediated mechanisms. Int J Biochem Cell Biol (2004) 0.94
CYP2C9 and VKORC1 genotypes in Puerto Ricans: A case for admixture-matching in clinical pharmacogenetic studies. Clin Chim Acta (2010) 0.93
Placental mesenchymal and cord blood stem cell therapy for dilated cardiomyopathy. Reprod Biomed Online (2008) 0.93
Anti-angiogenic effect of high doses of ascorbic acid. J Transl Med (2008) 0.92
Stem cell therapy for autism. J Transl Med (2007) 0.91
Cancer is a functional repair tissue. Med Hypotheses (2005) 0.89
Prediction of warfarin dose reductions in Puerto Rican patients, based on combinatorial CYP2C9 and VKORC1 genotypes. Ann Pharmacother (2012) 0.87
L-ascorbic acid represses constitutive activation of NF-kappaB and COX-2 expression in human acute myeloid leukemia, HL-60. J Cell Biochem (2004) 0.87
Autologous stromal vascular fraction cells: a tool for facilitating tolerance in rheumatic disease. Cell Immunol (2010) 0.86
The king is dead, long live the king: entering a new era of stem cell research and clinical development. J Transl Med (2011) 0.86
Dietary patterns and their association with sociodemographic characteristics and perceived academic stress of college students in Puerto Rico. P R Health Sci J (2013) 0.86
Inhibition of intracranial glioma growth by endometrial regenerative cells. Cell Cycle (2009) 0.85
Combination stem cell therapy for heart failure. Int Arch Med (2010) 0.85
Implementing genotype-guided antithrombotic therapy. Future Cardiol (2010) 0.85
Circulating endothelial progenitor cells: a new approach to anti-aging medicine? J Transl Med (2009) 0.84
The bio-energetic theory of carcinogenesis. Med Hypotheses (2012) 0.83
Could metabolic syndrome, lipodystrophy, and aging be mesenchymal stem cell exhaustion syndromes? Stem Cells Int (2011) 0.83
Antigen-specific therapy of rheumatoid arthritis. Expert Opin Biol Ther (2008) 0.83
Effects of high dose ascorbate administration on L-10 tumor growth in guinea pigs. P R Health Sci J (2005) 0.82
Autologous stromal vascular fraction therapy for rheumatoid arthritis: rationale and clinical safety. Int Arch Med (2012) 0.82
Intravenous ascorbic acid to prevent and treat cancer-associated sepsis? J Transl Med (2011) 0.81
Why admixture matters in genetically-guided therapy: missed targets in the COAG and EU-PACT trials. P R Health Sci J (2015) 0.81
Intravenous ascorbic acid as a treatment for severe jellyfish stings. P R Health Sci J (2004) 0.80
Prevalence of CYP2C19 gene polymorphisms in the Puerto Rican population: a preliminary report. P R Health Sci J (2008) 0.80
Erythrocyte membrane fatty acid composition in cancer patients. P R Health Sci J (2004) 0.80
Caffeinated-beverage consumption and its association with socio-demographic characteristics and self-perceived academic stress in first and second year students at the University of Puerto Rico Medical Sciences Campus (UPR-MSC). P R Health Sci J (2013) 0.80
On the missing link between inflammation and cancer. Dermatol Online J (2011) 0.80
Development of a pharmacogenetic-guided warfarin dosing algorithm for Puerto Rican patients. Pharmacogenomics (2012) 0.79
Activation of Raf1 and the ERK pathway in response to l-ascorbic acid in acute myeloid leukemia cells. Cell Signal (2005) 0.79
Mitochondria, Energy and Cancer: The Relationship with Ascorbic Acid. J Orthomol Med (2010) 0.79
Immune effects of mesenchymal stem cells: implications for Charcot-Marie-Tooth disease. Cell Immunol (2008) 0.79
Pharmacogenetics of drug-metabolizing enzymes in US Hispanics. Drug Metabol Personal Ther (2015) 0.78
Inhibition of human breast carcinoma cell proliferation by ascorbate and copper. P R Health Sci J (2002) 0.78
Cell membrane fatty acid composition differs between normal and malignant cell lines. P R Health Sci J (2004) 0.78
Effects of a high molecular mass Convolvulus arvensis extract on tumor growth and angiogenesis. P R Health Sci J (2002) 0.78
Frequencies of Functional Polymorphisms in Three Pharmacokinetic Genes of Clinical Interest within the Admixed Puerto Rican Population. J Pharmacogenomics Pharmacoproteomics (2013) 0.78
Biodistribution of liposome-entrapped human gamma-globulin. Biopharm Drug Dispos (2006) 0.78
Alcohol consumption and smoking and their associations with socio-demographic characteristics, dietary patterns, and perceived academic stress in Puerto Rican college students. P R Health Sci J (2013) 0.78
A novel method of modifying immune responses by vaccination with lipiodol-siRNA mixtures. J Transl Med (2006) 0.78
Tumor growth parameters of in-vivo human breast carcinoma: a proposed mathematical model for tumor growth kinetics. P R Health Sci J (2006) 0.77
Non-medical use of prescription drugs and its association with socio-demographic characteristics, dietary pattern, and perceived academic load and stress in college students in Puerto Rico. P R Health Sci J (2013) 0.77
Integrating genomic based information into clinical warfarin (Coumadin) management: an illustrative case report. Conn Med (2008) 0.77
'Generic to genetic' transition in cardiovascular and neuropsychiatric drugs: opportunity for personalized medicine. Pharmacogenomics (2012) 0.77
Physical activity and its associations with sociodemographic characteristics, dietary patterns, and perceived academic stress in students attending college in Puerto Rico. P R Health Sci J (2013) 0.77
Metabolic Correction as a tool to improve diabetes type 2 management. Bol Asoc Med P R (2015) 0.76
Orthomolecular oncology: a mechanistic view of intravenous ascorbate's chemotherapeutic activity. P R Health Sci J (2002) 0.76
Pharmacogenetic association study of warfarin safety endpoints in Puerto Ricans. P R Health Sci J (2014) 0.76
Intravenous ascorbic acid as an adjuvant to interleukin-2 immunotherapy. J Transl Med (2014) 0.76
Supraphysiological cyclic dosing of sustained release T3 in order to reset low basal body temperature. P R Health Sci J (2006) 0.76